Keros Therapeutics, Inc. (KROS) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Keros Therapeutics, Inc. (KROS) closed at USD 11.05 on 2026-10-14, a change of -27.2 % over the past year, with a market capitalization of USD 220.08M.

Keros Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Keros Therapeutics, Inc. key figures

Previous close

USD 11.05 (2026-10-14)

1-year change

-27.2 %

Market cap

USD 220.08M

Enterprise value

USD -21.8M

P/E ratio (trailing)

-3.45

P/E ratio (forward)

-1.68

EPS (trailing)

-3.22

EPS (forward)

-6.62

PEG ratio

n/a

Price to book

0.84

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.41

Employees

92

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Keros Therapeutics, Inc.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. It develops rinvatercept, which acts as a ligand trap and inhibits the biological effects of myostatin and activin A in Phase 1 clinical trials for Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis; and elritercept to target TGF-ß signaling pathways to address diseases that arise from ineffective hematopoiesis in Phase 3 clinical trials for Myelodysplastic Syndromes and Phase 2 clinical trials for Myelofibrosis. The company has collaboration and license agreements with Hansoh (Shanghai) Healthtech Co., Ltd. to develop, manufacture, and commercialize elritercept and licensed products containing elritercept; and Takeda Pharmaceuticals U.S.A., Inc. to develop, manufacture, and commercialize elritercept and certain derivative compounds. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Keros Therapeutics, Inc. and compare it with other stocks.